HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACID

The aim of the work is to evaluate the hemostimulating activity of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) conjugates with alendronic acid (ALN) in the model of cytostatic myelosuppression and the dynamics of rhGM-CSF accumulation as a part of the conjugate in t...

Full description

Bibliographic Details
Main Authors: G. G. Shimina, A. V. Bateneva, E. S. Tsyplenkova, S. G. Gamaley, T. I. Esina, E. A. Volosnikova, E. D. Danilenko
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2022-12-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
Online Access:https://www.pharmpharm.ru/jour/article/view/1198
_version_ 1797874683103674368
author G. G. Shimina
A. V. Bateneva
E. S. Tsyplenkova
S. G. Gamaley
T. I. Esina
E. A. Volosnikova
E. D. Danilenko
author_facet G. G. Shimina
A. V. Bateneva
E. S. Tsyplenkova
S. G. Gamaley
T. I. Esina
E. A. Volosnikova
E. D. Danilenko
author_sort G. G. Shimina
collection DOAJ
description The aim of the work is to evaluate the hemostimulating activity of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) conjugates with alendronic acid (ALN) in the model of cytostatic myelosuppression and the dynamics of rhGM-CSF accumulation as a part of the conjugate in the bone tissue and bone marrow of mice.Materials and methods. The conjugates obtained by a solid-phase synthesis using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide or periodate oxidation, were used. A hemostimulating activity was evaluated in a model of a cytostatic myelosuppression induced by the administration of cyclophosphamide to CBA/Calac mice. RhGM-CSF preparations were injected subcutaneously for 4-5 days at the dose of 90 µg/kg. After the injections cycle had been completed, the total leukocyte and segmented neutrophil counts were carried out in the blood samples, and the total karyocyte count was carried out in the bone marrow samples.The tissue distribution of rhGM-CSF preparations was assessed in outbred CD-1 mice after a single intravenous administration at the effective dose. The content of rhGM-CSF in blood, femoral tissue and bone marrow was determined by enzyme immunoassay.Results. RhGM-CSF conjugates with ALN have been shown to retain the ability of the original protein to increase the number of leukocytes, segmented blood neutrophils, and bone marrow karyocytes under the action of conjugates. The stimulation of the neutrophil production used to be observed at earlier times than in the case of rhGM-CSF. The increase in the total number of bone marrow cells after the introduction of all three conjugates was more pronounced compared to the original protein (by 34%). The increased hemostimulatory effect of the AEG conjugate was accompanied by a more intense accumulation of rhGM-CSF in the bone tissue and bone marrow of mice. The rhGM-CSF introduced into the conjugate was detected in the bone tissue for 24 h and it circulated in the bloodstream for a longer time compared to the original protein.Conclusion. The data obtained make it possible to conclude that further work on the development of effective hemostimulating drugs based on rhGM-CSF conjugates with ALN, is promising.
first_indexed 2024-04-10T01:35:55Z
format Article
id doaj.art-666d6449a7d74ae783613f5fb3fa7ff5
institution Directory Open Access Journal
issn 2307-9266
2413-2241
language Russian
last_indexed 2024-04-10T01:35:55Z
publishDate 2022-12-01
publisher Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
record_format Article
series Фармация и фармакология (Пятигорск)
spelling doaj.art-666d6449a7d74ae783613f5fb3fa7ff52023-03-13T09:18:13ZrusVolgograd State Medical University, Pyatigorsk Medical and Pharmaceutical InstituteФармация и фармакология (Пятигорск)2307-92662413-22412022-12-0110547248210.19163/2307-9266-2022-10-5-472-482458HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACIDG. G. Shimina0A. V. Bateneva1E. S. Tsyplenkova2S. G. Gamaley3T. I. Esina4E. A. Volosnikova5E. D. Danilenko6Институт медицинской биотехнологии Федерального бюджетного учреждения науки «Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаИнститут медицинской биотехнологии Федерального бюджетного учреждения науки «Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаИнститут медицинской биотехнологии Федерального бюджетного учреждения науки «Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаИнститут медицинской биотехнологии Федерального бюджетного учреждения науки «Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаИнститут медицинской биотехнологии Федерального бюджетного учреждения науки «Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаИнститут медицинской биотехнологии Федерального бюджетного учреждения науки «Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаИнститут медицинской биотехнологии Федерального бюджетного учреждения науки «Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человекаThe aim of the work is to evaluate the hemostimulating activity of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) conjugates with alendronic acid (ALN) in the model of cytostatic myelosuppression and the dynamics of rhGM-CSF accumulation as a part of the conjugate in the bone tissue and bone marrow of mice.Materials and methods. The conjugates obtained by a solid-phase synthesis using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide or periodate oxidation, were used. A hemostimulating activity was evaluated in a model of a cytostatic myelosuppression induced by the administration of cyclophosphamide to CBA/Calac mice. RhGM-CSF preparations were injected subcutaneously for 4-5 days at the dose of 90 µg/kg. After the injections cycle had been completed, the total leukocyte and segmented neutrophil counts were carried out in the blood samples, and the total karyocyte count was carried out in the bone marrow samples.The tissue distribution of rhGM-CSF preparations was assessed in outbred CD-1 mice after a single intravenous administration at the effective dose. The content of rhGM-CSF in blood, femoral tissue and bone marrow was determined by enzyme immunoassay.Results. RhGM-CSF conjugates with ALN have been shown to retain the ability of the original protein to increase the number of leukocytes, segmented blood neutrophils, and bone marrow karyocytes under the action of conjugates. The stimulation of the neutrophil production used to be observed at earlier times than in the case of rhGM-CSF. The increase in the total number of bone marrow cells after the introduction of all three conjugates was more pronounced compared to the original protein (by 34%). The increased hemostimulatory effect of the AEG conjugate was accompanied by a more intense accumulation of rhGM-CSF in the bone tissue and bone marrow of mice. The rhGM-CSF introduced into the conjugate was detected in the bone tissue for 24 h and it circulated in the bloodstream for a longer time compared to the original protein.Conclusion. The data obtained make it possible to conclude that further work on the development of effective hemostimulating drugs based on rhGM-CSF conjugates with ALN, is promising.https://www.pharmpharm.ru/jour/article/view/1198рекомбинантный гранулоцитарно-макрофагальный колониестимулирующий фактор человекаалендроновая кислотаконъюгатгемостимулирующая активностьнакопление в костной ткани и костном мозге
spellingShingle G. G. Shimina
A. V. Bateneva
E. S. Tsyplenkova
S. G. Gamaley
T. I. Esina
E. A. Volosnikova
E. D. Danilenko
HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACID
Фармация и фармакология (Пятигорск)
рекомбинантный гранулоцитарно-макрофагальный колониестимулирующий фактор человека
алендроновая кислота
конъюгат
гемостимулирующая активность
накопление в костной ткани и костном мозге
title HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACID
title_full HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACID
title_fullStr HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACID
title_full_unstemmed HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACID
title_short HEMOSTIMULATING PROPERTIES OF THE CONJUGATES OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR WITH ALENDRONIC ACID
title_sort hemostimulating properties of the conjugates of granulocyte macrophage colony stimulating factor with alendronic acid
topic рекомбинантный гранулоцитарно-макрофагальный колониестимулирующий фактор человека
алендроновая кислота
конъюгат
гемостимулирующая активность
накопление в костной ткани и костном мозге
url https://www.pharmpharm.ru/jour/article/view/1198
work_keys_str_mv AT ggshimina hemostimulatingpropertiesoftheconjugatesofgranulocytemacrophagecolonystimulatingfactorwithalendronicacid
AT avbateneva hemostimulatingpropertiesoftheconjugatesofgranulocytemacrophagecolonystimulatingfactorwithalendronicacid
AT estsyplenkova hemostimulatingpropertiesoftheconjugatesofgranulocytemacrophagecolonystimulatingfactorwithalendronicacid
AT sggamaley hemostimulatingpropertiesoftheconjugatesofgranulocytemacrophagecolonystimulatingfactorwithalendronicacid
AT tiesina hemostimulatingpropertiesoftheconjugatesofgranulocytemacrophagecolonystimulatingfactorwithalendronicacid
AT eavolosnikova hemostimulatingpropertiesoftheconjugatesofgranulocytemacrophagecolonystimulatingfactorwithalendronicacid
AT eddanilenko hemostimulatingpropertiesoftheconjugatesofgranulocytemacrophagecolonystimulatingfactorwithalendronicacid